Olivia Hughes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olivia Hughes has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Robert Thompson
Doctoral Programme in Clinical Psychology, Cardiff & Vale University Health Board & School of Psychology, Cardiff University , Cardiff, Wales
6 shared publications - Katherine H. Shelton
School of Psychology, Cardiff University, Cardiff, UK
3 shared publications Anthony Bewley
Department of Dermatology, Royal London Hospital, Bart’s Health NHS Trust, & Queen Mary University London , London
2 shared publications- Bernd W. M. Arents
Dutch Association for People with Atopic Dermatitis Nijkerk the Netherlands
2 shared publications Catherine H Smith
St John’s Institute of Dermatology, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust , London
2 shared publications- Helen Penny
Aneurin Bevan University Health Board, UK
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Understanding the Experiences and Needs of Parents With Children With Epidermolysis Bullosa. A Qualitative Study to Inform the Development of a Self-help Toolkit
Background: Epidermolysis Bullosa (EB) is a rare genetic condition characterised by skin fragility and blistering. There is no cure for EB and management includes wound care, dressing changes, and medications for pain relief and chronic itch. Parents of children with EB have a significant additional caregiving role, including provision of physical care, and this alongside other aspects of the condition can put parents at risk of psychological stress and distress. Objectives: The primary aim of this study was to understand the support needs of parent caregivers of children with EB. A secondary aim was to consider how these needs might be addressed with the development of a self-help toolkit. Methods: Thematic analysis using semi-structured interviews conducted with both parents of children with EB and expert healthcare professionals (HCPs). Results: Parents described experiencing a range of complex emotions, including sadness, worry and uncertainty about the future, and guilt. The interviews with HCPs supported the parental accounts and highlighted the need for a tailored psychosocial self-help intervention. The findings suggest that a self-help intervention would need to acknowledge the wider family impact alongside recognition that considerable psychosocial impact is associated with the provision of continuing care. Conclusions: Future psychosocial interventions must be designed around the needs of families, with a systemic approach to include siblings and the wider family unit. Approaches drawing on acceptance and commitment therapy might also be particularly relevant to this population but only if adapted to consider systemic issues.
- 29 October 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessUnderstanding the Experiences and Needs of Parents With Children With Epidermolysis Bullosa. A Qualitative Study to Inform the Development of a Self-help Toolkit
Background: Epidermolysis Bullosa (EB) is a rare genetic condition characterised by skin fragility and blistering. There is no cure for EB and management includes wound care, dressing changes, and medications for pain relief and chronic itch. Parents of children with EB have a significant additional caregiving role, including provision of physical care, and this alongside other aspects of the condition can put parents at risk of psychological stress and distress. Objectives: The primary aim of this study was to understand the support needs of parent caregivers of children with EB. A secondary aim was to consider how these needs might be addressed with the development of a self-help toolkit. Methods: Thematic analysis using semi-structured interviews conducted with both parents of children with EB and expert healthcare professionals (HCPs). Results: Parents described experiencing a range of complex emotions, including sadness, worry and uncertainty about the future, and guilt. The interviews with HCPs supported the parental accounts and highlighted the need for a tailored psychosocial self-help intervention. The findings suggest that a self-help intervention would need to acknowledge the wider family impact alongside recognition that considerable psychosocial impact is associated with the provision of continuing care. Conclusions: Future psychosocial interventions must be designed around the needs of families, with a systemic approach to include siblings and the wider family unit. Approaches drawing on acceptance and commitment therapy might also be particularly relevant to this population but only if adapted to consider systemic issues.
- 30 April 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (2) , 349-351
Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis
In this cohort study of 11 034 treatment episodes from the BADBIR register, we evaluated the risk of serious infection associated with certolizumab compared with other systemic treatments in women with psoriasis aged ≤ 50 years. After inverse probability weighting and recurrent event modelling, certolizumab was associated with a higher risk of serious infection compared with adalimumab and ustekinumab. Although residual confounding by indication and slight age imbalance cannot be excluded, these findings suggest a modestly increased infection risk with certolizumab in this population.
- 30 April 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (2) , 349-351
Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis
In this cohort study of 11 034 treatment episodes from the BADBIR register, we evaluated the risk of serious infection associated with certolizumab compared with other systemic treatments in women with psoriasis aged ≤ 50 years. After inverse probability weighting and recurrent event modelling, certolizumab was associated with a higher risk of serious infection compared with adalimumab and ustekinumab. Although residual confounding by indication and slight age imbalance cannot be excluded, these findings suggest a modestly increased infection risk with certolizumab in this population.
- Open Access
- 16 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (1) , 58-67
Using biologic therapies as first-line systemic treatment for psoriasis: a cohort study following the target trial emulation framework using data from the British Association of Dermatologists Biologics and Immunomodulators Register
Background: Current treatment pathways for moderate-to-severe psoriasis in the UK and the Republic of Ireland direct initiation of targeted biologic immunomodulators when conventional systemic drugs are ineffective or not tolerated. Starting biologics early in the treatment pathway may modify disease course and improve short- and long-term outcomes. Objectives: To compare the effectiveness and risk of incident comorbid conditions over 5 years when initiating a biologic as the first systemic treatment vs. the current standard of care, in which the patients started with a conventional non-biologic systemic therapy with possible subsequent switch to biologics. Methods: This study applied the target trial emulation framework using data from the British Association of Dermatologists Biologics and Immunomodulators Register. Adults (aged ≥ 18 years) with moderate-to-severe psoriasis [baseline Psoriasis Area and Severity Index (PASI) ≥ 10] and no prior systemic therapy were included. Five-year trajectories of PASI and Dermatology Life Quality Index (DLQI) were modelled using mixed-effects repeated-measures models. The probability of complete skin clearance (PASI 0) and the risk of developing long-term comorbidities (cardiovascular, hepatic, neoplastic, metabolic, mental health or musculoskeletal disorders, and incident psoriatic arthritis) were estimated using marginal structural models with stabilized inverse probability weighting to adjust for baseline and time-varying confounding. Results: We included 3702 patients: 3368 followed the current standard of care and 334 initiated a biologic as first-line systemic therapy. At 5 years, the modelled mean PASI was 4.7 [95% confidence interval (CI) 4.0–5.4] for standard of care and 2.0 (95% CI 1.2–2.7) for biologic initiators; DLQI were 5.6 (95% CI 4.2–7.0) and 3.5 (95% CI 1.3–5.7), respectively. The cumulative rate of achieving PASI 0 was 32.2 vs. 58.6%, with a higher likelihood of PASI 0 for biologic initiators [hazard ratio (HR) 2.85, 95% CI 2.34–3.47]. The cumulative risk of chronic comorbidities was lower among biologic initiators (47.5 vs. 54.3%; HR 0.72, 95% CI 0.58–0.89), with lower risks of mental health (HR 0.64, 95% CI 0.44–0.94) and hepatic (HR 0.54, 95% CI 0.38–0.76) disorders. Conclusions: Initiating biologics as the first systemic therapy was associated with better clinical outcomes compared with standard stepwise approaches. Our results support reconsideration of existing pathways to allow earlier use of biologics.
- 16 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (1) , 58-67
Open AccessUsing biologic therapies as first-line systemic treatment for psoriasis: a cohort study following the target trial emulation framework using data from the British Association of Dermatologists Biologics and Immunomodulators Register
Background: Current treatment pathways for moderate-to-severe psoriasis in the UK and the Republic of Ireland direct initiation of targeted biologic immunomodulators when conventional systemic drugs are ineffective or not tolerated. Starting biologics early in the treatment pathway may modify disease course and improve short- and long-term outcomes. Objectives: To compare the effectiveness and risk of incident comorbid conditions over 5 years when initiating a biologic as the first systemic treatment vs. the current standard of care, in which the patients started with a conventional non-biologic systemic therapy with possible subsequent switch to biologics. Methods: This study applied the target trial emulation framework using data from the British Association of Dermatologists Biologics and Immunomodulators Register. Adults (aged ≥ 18 years) with moderate-to-severe psoriasis [baseline Psoriasis Area and Severity Index (PASI) ≥ 10] and no prior systemic therapy were included. Five-year trajectories of PASI and Dermatology Life Quality Index (DLQI) were modelled using mixed-effects repeated-measures models. The probability of complete skin clearance (PASI 0) and the risk of developing long-term comorbidities (cardiovascular, hepatic, neoplastic, metabolic, mental health or musculoskeletal disorders, and incident psoriatic arthritis) were estimated using marginal structural models with stabilized inverse probability weighting to adjust for baseline and time-varying confounding. Results: We included 3702 patients: 3368 followed the current standard of care and 334 initiated a biologic as first-line systemic therapy. At 5 years, the modelled mean PASI was 4.7 [95% confidence interval (CI) 4.0–5.4] for standard of care and 2.0 (95% CI 1.2–2.7) for biologic initiators; DLQI were 5.6 (95% CI 4.2–7.0) and 3.5 (95% CI 1.3–5.7), respectively. The cumulative rate of achieving PASI 0 was 32.2 vs. 58.6%, with a higher likelihood of PASI 0 for biologic initiators [hazard ratio (HR) 2.85, 95% CI 2.34–3.47]. The cumulative risk of chronic comorbidities was lower among biologic initiators (47.5 vs. 54.3%; HR 0.72, 95% CI 0.58–0.89), with lower risks of mental health (HR 0.64, 95% CI 0.44–0.94) and hepatic (HR 0.54, 95% CI 0.38–0.76) disorders. Conclusions: Initiating biologics as the first systemic therapy was associated with better clinical outcomes compared with standard stepwise approaches. Our results support reconsideration of existing pathways to allow earlier use of biologics.
- Open Access
- 1 July 2025
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 5 (4) , 281-288
Topical steroid withdrawal: self-diagnosis, unconscious bias and social media
Background: Consensus amongst dermatologists regarding the phenomenon of topical steroid withdrawal (TSW) is elusive. This may be contrasted with a growing online patient movement, including social media communities. Objectives: This study aimed to investigate dermatologist perspectives regarding TSW and to assess attitudes towards self-diagnosis. Methods: A two-part online questionnaire was disseminated to UK-based Dermatology Consultants, Registrars and Fellows. Section one presented a clinical scenario and randomized respondents into two groups: one mentioning TSW self-diagnosis, and an otherwise identical control without the self-diagnosis. Questions about the clinical scenario were directed to dermatologists and focused on attitudes regarding patient-predicted behaviours. Section two asked about TSW perceptions and experiences, and thematic analysis of open text responses was undertaken. Results: One hundred and three responses were received, including 51 Consultants, 38 Trainee Dermatologists, 10 Dermatology Fellows, 3 Specialty And Specialist (SAS) Dermatology doctors and 1 Post-CCT (Certificate of Completion of Training) Fellow. Thirty-four percent (n = 35/103) of respondents considered TSW to be a distinct clinical entity, 17.5% (n = 18/103) did not and 48.5% (n = 50/103) were unsure. Respondents felt that self-diagnosing TSW patients were less likely to comply with treatment, and more likely to take up time and pose management problems compared with controls. Themes of uncertainty regarding diagnostic veracity and social media misinformation were identified. Conclusions: Uncertainty regarding the veracity of a TSW diagnosis and its management is common amongst dermatology healthcare professionals (HCPs). Dermatology HCPs in this study considered that patients who self-diagnosed TSW were more difficult to engage with skin disease management. Dermatologists desire further understanding of and research into the nature and management of TSW.
- 1 July 2025
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 5 (4) , 281-288
Open AccessTopical steroid withdrawal: self-diagnosis, unconscious bias and social media
Background: Consensus amongst dermatologists regarding the phenomenon of topical steroid withdrawal (TSW) is elusive. This may be contrasted with a growing online patient movement, including social media communities. Objectives: This study aimed to investigate dermatologist perspectives regarding TSW and to assess attitudes towards self-diagnosis. Methods: A two-part online questionnaire was disseminated to UK-based Dermatology Consultants, Registrars and Fellows. Section one presented a clinical scenario and randomized respondents into two groups: one mentioning TSW self-diagnosis, and an otherwise identical control without the self-diagnosis. Questions about the clinical scenario were directed to dermatologists and focused on attitudes regarding patient-predicted behaviours. Section two asked about TSW perceptions and experiences, and thematic analysis of open text responses was undertaken. Results: One hundred and three responses were received, including 51 Consultants, 38 Trainee Dermatologists, 10 Dermatology Fellows, 3 Specialty And Specialist (SAS) Dermatology doctors and 1 Post-CCT (Certificate of Completion of Training) Fellow. Thirty-four percent (n = 35/103) of respondents considered TSW to be a distinct clinical entity, 17.5% (n = 18/103) did not and 48.5% (n = 50/103) were unsure. Respondents felt that self-diagnosing TSW patients were less likely to comply with treatment, and more likely to take up time and pose management problems compared with controls. Themes of uncertainty regarding diagnostic veracity and social media misinformation were identified. Conclusions: Uncertainty regarding the veracity of a TSW diagnosis and its management is common amongst dermatology healthcare professionals (HCPs). Dermatology HCPs in this study considered that patients who self-diagnosed TSW were more difficult to engage with skin disease management. Dermatologists desire further understanding of and research into the nature and management of TSW.
- Open Access
- 29 October 2024
- Published by Wiley in British Journal of Health Psychology
- Vol. 30 (1)
Impact of childhood psoriasis on children and parents during transition to adolescence: An interpretative phenomenological analysis
Objectives: Psoriasis is a chronic skin condition that can develop at any age. Childhood psoriasis can lead to stigmatization and reduced quality of life in children and parents. This study aimed to gather a detailed family‐level understanding of the experience of childhood psoriasis during the time of transition to adolescence. Design: A multi‐perspectival interpretative phenomenological analysis (IPA) was used. Methods: Sixteen semi‐structured interviews with eight parent–child dyads were conducted and analysed in accordance with IPA principles. Results: Three superordinate themes and three sub‐themes were identified: 1. ‘Transition and transaction’ including: 1.1 ‘Shifting responsibilities and self‐efficacy’; 2. ‘Stigma and social impact’; and 3. ‘The treatment journey’ including: 3.1 ‘Finding an effective treatment’, 3.2 ‘Coping with on‐going management’. Uncertainties surrounding treatment options were an initial focus of difficulty for families. In adolescence, the difficulty shifted to be more identity focussed as the responsibility for disease management and the increased awareness on body image posed added challenges. Both parents and children described visibility and stigma as the most distressing aspects of living with psoriasis and experienced negative emotions that resurfaced during adolescence. Conclusions: This study suggests that childhood psoriasis can have a significant impact on children, particularly as they begin to transition to adolescence. Findings also highlight the burden of psoriasis for parents. As such, psychological interventions (such as adapted forms of mindfulness‐based Cognitive‐Behavioural‐Therapy) are needed to target and reduce stress. Such interventions are likely to require a systemic focus and support validation of the real impact and fear of stigmatization.
- 29 October 2024
- Published by Wiley in British Journal of Health Psychology
- Vol. 30 (1)
Open AccessImpact of childhood psoriasis on children and parents during transition to adolescence: An interpretative phenomenological analysis
Objectives: Psoriasis is a chronic skin condition that can develop at any age. Childhood psoriasis can lead to stigmatization and reduced quality of life in children and parents. This study aimed to gather a detailed family‐level understanding of the experience of childhood psoriasis during the time of transition to adolescence. Design: A multi‐perspectival interpretative phenomenological analysis (IPA) was used. Methods: Sixteen semi‐structured interviews with eight parent–child dyads were conducted and analysed in accordance with IPA principles. Results: Three superordinate themes and three sub‐themes were identified: 1. ‘Transition and transaction’ including: 1.1 ‘Shifting responsibilities and self‐efficacy’; 2. ‘Stigma and social impact’; and 3. ‘The treatment journey’ including: 3.1 ‘Finding an effective treatment’, 3.2 ‘Coping with on‐going management’. Uncertainties surrounding treatment options were an initial focus of difficulty for families. In adolescence, the difficulty shifted to be more identity focussed as the responsibility for disease management and the increased awareness on body image posed added challenges. Both parents and children described visibility and stigma as the most distressing aspects of living with psoriasis and experienced negative emotions that resurfaced during adolescence. Conclusions: This study suggests that childhood psoriasis can have a significant impact on children, particularly as they begin to transition to adolescence. Findings also highlight the burden of psoriasis for parents. As such, psychological interventions (such as adapted forms of mindfulness‐based Cognitive‐Behavioural‐Therapy) are needed to target and reduce stress. Such interventions are likely to require a systemic focus and support validation of the real impact and fear of stigmatization.
- Open Access
- 21 October 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 804-811
Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Background: Psoriasis is associated with poor mental health and reduced quality of life. Although the high risk for depression in patients with psoriasis is well established, the suicidality risk among these patients is uncertain. Previous studies provide contrasting results and have not included patients with clinically confirmed severe disease. Objectives: To determine the risk of suicide among patients with moderate to severe psoriasis and to compare it with that of the general population, and to investigate if psychiatric comorbidity or history of suicidality increases future suicidality risk in psoriasis. We further estimated the incidence of suicidal and self-injurious behaviours in patients. Methods: Analysis was performed using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). General population mortality and suicide data were used as controls. Results: There were nine suicides in BADBIR. The incidence rate of suicide was 12.5 per 100 000 person-years [95% confidence interval (CI) 6.53–24.11] in BADBIR vs. 11.0 per 100 000 person-years (95% CI 10.7–11.3) in the general population in England and Wales. Among patients, psychiatric comorbidity or past suicidality was associated with a higher risk for suicidal ideation, suicide attempts and self-injurious behaviours. Conclusions: The suicide rate among patients with moderate to severe psoriasis was not significantly higher when compared with the general population. Suicide is a rare event and our results are limited by uncertainty about the reliability of the estimate. However, considering the high depression prevalence in psoriasis, our findings support the need for prompt assessment of patients for psychiatric comorbidities and suicidality history. Further research is required on suicidal behaviours and the role of psoriasis severity.
- 21 October 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (4) , 804-811
Open AccessRisk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Background: Psoriasis is associated with poor mental health and reduced quality of life. Although the high risk for depression in patients with psoriasis is well established, the suicidality risk among these patients is uncertain. Previous studies provide contrasting results and have not included patients with clinically confirmed severe disease. Objectives: To determine the risk of suicide among patients with moderate to severe psoriasis and to compare it with that of the general population, and to investigate if psychiatric comorbidity or history of suicidality increases future suicidality risk in psoriasis. We further estimated the incidence of suicidal and self-injurious behaviours in patients. Methods: Analysis was performed using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). General population mortality and suicide data were used as controls. Results: There were nine suicides in BADBIR. The incidence rate of suicide was 12.5 per 100 000 person-years [95% confidence interval (CI) 6.53–24.11] in BADBIR vs. 11.0 per 100 000 person-years (95% CI 10.7–11.3) in the general population in England and Wales. Among patients, psychiatric comorbidity or past suicidality was associated with a higher risk for suicidal ideation, suicide attempts and self-injurious behaviours. Conclusions: The suicide rate among patients with moderate to severe psoriasis was not significantly higher when compared with the general population. Suicide is a rare event and our results are limited by uncertainty about the reliability of the estimate. However, considering the high depression prevalence in psoriasis, our findings support the need for prompt assessment of patients for psychiatric comorbidities and suicidality history. Further research is required on suicidal behaviours and the role of psoriasis severity.
- Open Access
- 30 September 2024
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 52 (6) , 561-580
‘Living in the Present’ mindfulness for parents of children with skin conditions: a single group case series
Background: Parents of children with skin conditions can experience stress from the additional responsibilities of care. However, there is a lack of psychological interventions for families affected by a dermatological diagnosis.Aims: To investigate (1) whether delivering the ‘Living in the Present’ mindfulness curriculum to parents of children with skin conditions reduced stress and increased both parental/child quality of life (QoL), and (2) determine intervention acceptability.Method: Ten parents of children with eczema, ectodermal dysplasia, ichthyosis, and alopecia took part in a mindfulness-based intervention. Using mixed methods, a single-group experimental case design (SCED) was conducted and supplemented by thematic analysis of exit interviews. Parents completed idiographic measures of parenting stress, standardised measures of QoL, stress, mindfulness, and took part in exit interviews. Children also completed QoL measures.Results: Tau-U analysis of idiographic measures revealed three parents showed some significant improvements in positive targets, and five parents showed some significant improvements in negative targets. Assessment of reliable change demonstrated that: one parent showed improvement in mindful parenting, three parents showed improvement in parenting stress, seven parents showed improvement in anxiety, three parents showed improvements in depression, six parents showed improvement in QoL, and four children showed improvement in QoL. However, two parents showed increased anxiety. Thematic analysis revealed positive changes to mood following mindfulness, although challenges were highlighted, including sustaining home practice.Conclusion: Findings suggest this specific form of mindfulness intervention could be effective for parents of children with skin conditions; however, further robust studies are needed.
- 30 September 2024
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 52 (6) , 561-580
Open Access‘Living in the Present’ mindfulness for parents of children with skin conditions: a single group case series
Background: Parents of children with skin conditions can experience stress from the additional responsibilities of care. However, there is a lack of psychological interventions for families affected by a dermatological diagnosis.Aims: To investigate (1) whether delivering the ‘Living in the Present’ mindfulness curriculum to parents of children with skin conditions reduced stress and increased both parental/child quality of life (QoL), and (2) determine intervention acceptability.Method: Ten parents of children with eczema, ectodermal dysplasia, ichthyosis, and alopecia took part in a mindfulness-based intervention. Using mixed methods, a single-group experimental case design (SCED) was conducted and supplemented by thematic analysis of exit interviews. Parents completed idiographic measures of parenting stress, standardised measures of QoL, stress, mindfulness, and took part in exit interviews. Children also completed QoL measures.Results: Tau-U analysis of idiographic measures revealed three parents showed some significant improvements in positive targets, and five parents showed some significant improvements in negative targets. Assessment of reliable change demonstrated that: one parent showed improvement in mindful parenting, three parents showed improvement in parenting stress, seven parents showed improvement in anxiety, three parents showed improvements in depression, six parents showed improvement in QoL, and four children showed improvement in QoL. However, two parents showed increased anxiety. Thematic analysis revealed positive changes to mood following mindfulness, although challenges were highlighted, including sustaining home practice.Conclusion: Findings suggest this specific form of mindfulness intervention could be effective for parents of children with skin conditions; however, further robust studies are needed.
- Open Access
- 28 March 2024
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 4 (4) , e376
Healthcare Professionals’ Views on Psychological Support for Children and Families Affected by Skin Conditions in the UK: A Qualitative Study
Background: Skin conditions can have a psychological impact on a child and their caregivers, however, support is not equally distributed between geographical regions in the United Kingdom (UK). Objectives: This study aimed to investigate the experience of National Health Service (NHS) healthcare professionals (HCPs) of addressing the psychological needs of children with skin conditions and their families, and gain expert opinion as to how services need to further develop. Design: HCPs were recruited to a qualitative study with an advert posted on social media. Methods: Fifteen HCPs took part in interviews, including dermatologists (n = 4), dermatology nurse consultants/specialists (n = 4), clinical psychologists (n = 4), liaison psychiatrists (n = 2), and a children’s psychological well-being practitioner (n = 1). Results: Thematic analysis revealed children often presented with anxiety, depression, self-harm and suicidal ideation. The impact on caregivers was equally profound. There were differences in service provision across the UK and all HCPs recognised the urgent need for psychological support to be integrated into standard care. Participants described how a range of interventions are typically required including cognitive behavioural therapy (CBT), and systemic approaches, as well as mindfulness/third-wave approaches. Barriers to the delivery of psychological services were associated with a lack of funding and training opportunities for core and specialist staff alike. However, in some instances, participants had overcome these challenges to be able to deliver unique services. Conclusions: There exist several barriers to providing paediatric psychological interventions, and many locations across the UK remain vulnerable as a result of continuing lack of national guidelines for the provision of psychological services.
- 28 March 2024
- Published by Oxford University Press (OUP) in Skin Health and Disease
- Vol. 4 (4) , e376
Open AccessHealthcare Professionals’ Views on Psychological Support for Children and Families Affected by Skin Conditions in the UK: A Qualitative Study
Background: Skin conditions can have a psychological impact on a child and their caregivers, however, support is not equally distributed between geographical regions in the United Kingdom (UK). Objectives: This study aimed to investigate the experience of National Health Service (NHS) healthcare professionals (HCPs) of addressing the psychological needs of children with skin conditions and their families, and gain expert opinion as to how services need to further develop. Design: HCPs were recruited to a qualitative study with an advert posted on social media. Methods: Fifteen HCPs took part in interviews, including dermatologists (n = 4), dermatology nurse consultants/specialists (n = 4), clinical psychologists (n = 4), liaison psychiatrists (n = 2), and a children’s psychological well-being practitioner (n = 1). Results: Thematic analysis revealed children often presented with anxiety, depression, self-harm and suicidal ideation. The impact on caregivers was equally profound. There were differences in service provision across the UK and all HCPs recognised the urgent need for psychological support to be integrated into standard care. Participants described how a range of interventions are typically required including cognitive behavioural therapy (CBT), and systemic approaches, as well as mindfulness/third-wave approaches. Barriers to the delivery of psychological services were associated with a lack of funding and training opportunities for core and specialist staff alike. However, in some instances, participants had overcome these challenges to be able to deliver unique services. Conclusions: There exist several barriers to providing paediatric psychological interventions, and many locations across the UK remain vulnerable as a result of continuing lack of national guidelines for the provision of psychological services.
- Open Access
- 23 February 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (1) , 9-10
Dealing with flares in skin conditions: how can we meet patient need?
Olivia Hughes, Andrew R Thompson; Dealing with Flares in Skin Conditions: How Can We Meet Patient Need?, British Journal of Dermatology, , ljae084, https://doi.
- 23 February 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (1) , 9-10
Open AccessDealing with flares in skin conditions: how can we meet patient need?
Olivia Hughes, Andrew R Thompson; Dealing with Flares in Skin Conditions: How Can We Meet Patient Need?, British Journal of Dermatology, , ljae084, https://doi.
- Open Access
- 30 October 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (Supplement) , i11-i16
Is it really ever ‘just acne’? Considering the psychodermatology of acne
Acne can create a significant burden for people of all ages. However, the psychological consequences might often be overlooked. This review comments on recent evidence in the field of psychodermatology, to highlight the importance of considering a person's mental health in the treatment of acne. A range of presenting issues are discussed, and cases of underserved patients needing additional considerations are highlighted. This article considers how the psychological sequelae can contribute to the pathogenesis of acne, and discusses how psychotherapeutic approaches can be of benefit to people experiencing appearance-related distress. Importantly, attention is paid to the need for clinicians to assess a patient’s wellbeing alongside their physical symptoms. In doing this, early intervention can be facilitated if psychological comorbidities are present, with referral to appropriate specialist services, where available. To improve treatment outcomes, the skin and the mind must be addressed together in a multidisciplinary approach to dermatology care.
- 30 October 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (Supplement) , i11-i16
Open AccessIs it really ever ‘just acne’? Considering the psychodermatology of acne
Acne can create a significant burden for people of all ages. However, the psychological consequences might often be overlooked. This review comments on recent evidence in the field of psychodermatology, to highlight the importance of considering a person's mental health in the treatment of acne. A range of presenting issues are discussed, and cases of underserved patients needing additional considerations are highlighted. This article considers how the psychological sequelae can contribute to the pathogenesis of acne, and discusses how psychotherapeutic approaches can be of benefit to people experiencing appearance-related distress. Importantly, attention is paid to the need for clinicians to assess a patient’s wellbeing alongside their physical symptoms. In doing this, early intervention can be facilitated if psychological comorbidities are present, with referral to appropriate specialist services, where available. To improve treatment outcomes, the skin and the mind must be addressed together in a multidisciplinary approach to dermatology care.